Sloan Sheldon 4
4 · Spyre Therapeutics, Inc. · Filed Jan 17, 2025
Insider Transaction Report
Form 4
Sloan Sheldon
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-15+95,500→ 95,500 totalExercise: $21.66Exp: 2035-01-15→ Common Stock (95,500 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 95,500 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.